chr19-44905910-C-G

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 1P and 14B. PP2BP4_StrongBP6_ModerateBA1

The NM_001302688.2(APOE):​c.42C>G​(p.Asn14Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.641 in 1,293,628 control chromosomes in the GnomAD database, including 269,076 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.69 ( 37025 hom., cov: 29)
Exomes 𝑓: 0.63 ( 232051 hom. )

Consequence

APOE
NM_001302688.2 missense

Scores

11

Clinical Significance

Benign criteria provided, single submitter B:4

Conservation

PhyloP100: -2.66

Publications

112 publications found
Variant links:
Genes affected
APOE (HGNC:613): (apolipoprotein E) The protein encoded by this gene is a major apoprotein of the chylomicron. It binds to a specific liver and peripheral cell receptor, and is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. This gene maps to chromosome 19 in a cluster with the related apolipoprotein C1 and C2 genes. Mutations in this gene result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants. [provided by RefSeq, Jun 2016]
APOE Gene-Disease associations (from GenCC):
  • Alzheimer disease 2
    Inheritance: AD, Unknown Classification: DEFINITIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • hyperlipoproteinemia type 3
    Inheritance: AD, AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • lipoprotein glomerulopathy
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • sea-blue histiocyte syndrome
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 16 curated pathogenic missense variants (we use a threshold of 10). The gene has 2 curated benign missense variants. Gene score misZ: 0.74028 (below the threshold of 3.09). Trascript score misZ: -1.1126 (below the threshold of 3.09). GenCC associations: The gene is linked to hyperlipoproteinemia type 3, sea-blue histiocyte syndrome, lipoprotein glomerulopathy, Alzheimer disease 2.
BP4
Computational evidence support a benign effect (MetaRNN=9.173705E-7).
BP6
Variant 19-44905910-C-G is Benign according to our data. Variant chr19-44905910-C-G is described in ClinVar as Benign. ClinVar VariationId is 1175067.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.85 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001302688.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOE
NM_000041.4
MANE Select
c.-24+69C>G
intron
N/ANP_000032.1A0A0S2Z3D5
APOE
NM_001302688.2
c.42C>Gp.Asn14Lys
missense
Exon 1 of 4NP_001289617.1
APOE
NM_001302691.2
c.-39+69C>G
intron
N/ANP_001289620.1A0A0S2Z3D5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOE
ENST00000252486.9
TSL:1 MANE Select
c.-24+69C>G
intron
N/AENSP00000252486.3P02649
APOE
ENST00000485628.2
TSL:1
n.46+69C>G
intron
N/A
APOE
ENST00000434152.5
TSL:2
c.42C>Gp.Asn14Lys
missense
Exon 1 of 4ENSP00000413653.2H0Y7L5

Frequencies

GnomAD3 genomes
AF:
0.688
AC:
104386
AN:
151714
Hom.:
36967
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.857
Gnomad AMI
AF:
0.696
Gnomad AMR
AF:
0.590
Gnomad ASJ
AF:
0.622
Gnomad EAS
AF:
0.407
Gnomad SAS
AF:
0.521
Gnomad FIN
AF:
0.735
Gnomad MID
AF:
0.522
Gnomad NFE
AF:
0.638
Gnomad OTH
AF:
0.652
GnomAD2 exomes
AF:
0.604
AC:
84191
AN:
139394
AF XY:
0.598
show subpopulations
Gnomad AFR exome
AF:
0.863
Gnomad AMR exome
AF:
0.543
Gnomad ASJ exome
AF:
0.629
Gnomad EAS exome
AF:
0.395
Gnomad FIN exome
AF:
0.732
Gnomad NFE exome
AF:
0.635
Gnomad OTH exome
AF:
0.591
GnomAD4 exome
AF:
0.635
AC:
724609
AN:
1141796
Hom.:
232051
Cov.:
41
AF XY:
0.630
AC XY:
352673
AN XY:
560016
show subpopulations
African (AFR)
AF:
0.864
AC:
20217
AN:
23408
American (AMR)
AF:
0.545
AC:
14335
AN:
26288
Ashkenazi Jewish (ASJ)
AF:
0.628
AC:
9764
AN:
15552
East Asian (EAS)
AF:
0.413
AC:
5063
AN:
12264
South Asian (SAS)
AF:
0.523
AC:
39524
AN:
75558
European-Finnish (FIN)
AF:
0.727
AC:
19828
AN:
27270
Middle Eastern (MID)
AF:
0.556
AC:
1682
AN:
3026
European-Non Finnish (NFE)
AF:
0.642
AC:
589003
AN:
917346
Other (OTH)
AF:
0.613
AC:
25193
AN:
41084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
13483
26967
40450
53934
67417
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18108
36216
54324
72432
90540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.688
AC:
104514
AN:
151832
Hom.:
37025
Cov.:
29
AF XY:
0.688
AC XY:
51042
AN XY:
74182
show subpopulations
African (AFR)
AF:
0.857
AC:
35528
AN:
41440
American (AMR)
AF:
0.590
AC:
9007
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.622
AC:
2158
AN:
3470
East Asian (EAS)
AF:
0.408
AC:
2092
AN:
5126
South Asian (SAS)
AF:
0.521
AC:
2501
AN:
4800
European-Finnish (FIN)
AF:
0.735
AC:
7742
AN:
10540
Middle Eastern (MID)
AF:
0.520
AC:
153
AN:
294
European-Non Finnish (NFE)
AF:
0.638
AC:
43318
AN:
67890
Other (OTH)
AF:
0.656
AC:
1380
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1574
3147
4721
6294
7868
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
800
1600
2400
3200
4000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.622
Hom.:
7747
Bravo
AF:
0.684
TwinsUK
AF:
0.654
AC:
2426
ALSPAC
AF:
0.667
AC:
2569
ExAC
AF:
0.542
AC:
10611
Asia WGS
AF:
0.563
AC:
1961
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.72
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
0.77
DANN
Benign
0.51
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.021
N
LIST_S2
Benign
0.20
T
MetaRNN
Benign
9.2e-7
T
MetaSVM
Benign
-1.0
T
PhyloP100
-2.7
REVEL
Benign
0.013
ClinPred
0.0024
T
GERP RS
-3.6
PromoterAI
-0.032
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs440446; hg19: chr19-45409167; COSMIC: COSV52986063; COSMIC: COSV52986063; API